Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


16.09.2019

1 BMC Pediatr
18 Clin Infect Dis
1 J Infect
7 J Infect Dis
3 J Virol
1 JAMA
2 PLoS Comput Biol
3 PLoS One
36 Vaccine
1 Virology
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Pediatr

  1. GEIER DA, Kern JK, Geier MR
    Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s.
    BMC Pediatr. 2019;19:325.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. FAYE PM, Sonko MA, Diop A, Thiongane A, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  3. BONI-CISSE C, Jarju S, Bancroft RE, Lepri NA, et al
    Etiology of Bacterial Meningitis Among Children <5 Years Old in Cote d'Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  4. RENNER LA, Usuf E, Mohammed NI, Ansong D, et al
    Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  5. CASTELLI F
    Waiting for the malaria vaccine. The complex epidemiological transition towards malaria elimination.
    Clin Infect Dis. 2019 Aug 27. pii: 5555349. doi: 10.1093.
    PubMed     Text format    

  6. CHENG MP, Quach C, Marty FM
    Herpes Zoster Subunit Vaccination for Renal Transplant Recipients.
    Clin Infect Dis. 2019 Aug 24. pii: 5554150. doi: 10.1093.
    PubMed     Text format    

  7. LIU B, He WQ, Newall AT, Quinn HE, et al
    Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control study.
    Clin Infect Dis. 2019 Aug 26. pii: 5554689. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. AKECH S, Chepkirui M, Ogero M, Agweyu A, et al
    The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya.
    Clin Infect Dis. 2019 Aug 26. pii: 5554744. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. CROWCROFT NS
    Pertussis vaccine is only modestly effective in adults: Another piece in the pertussis puzzle.
    Clin Infect Dis. 2019 Aug 26. pii: 5554663. doi: 10.1093.
    PubMed     Text format    

  10. TAGBO BN, Bancroft RE, Fajolu I, Abdulkadir MB, et al
    Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  11. MPABALWANI EM, Lukwesa-Musyani C, Imamba A, Nakazwe R, et al
    Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  12. KOURNA HAMA M, Khan D, Laouali B, Okoi C, et al
    Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  13. SONKO MA, Dube FS, Okoi CB, Diop A, et al
    Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  14. SANNEH B, Okoi C, Grey-Johnson M, Bah-Camara H, et al
    Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  15. BOULA A, Senghore M, Ngoh R, Tassadjo F, et al
    Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaounde, Cameroon, in the Post-Vaccine Era.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  16. ANDRIATAHIRINTSOA EJPR, Raboba JL, Rahajamanana VL, Rakotozanany AL, et al
    Impact of 10-Valent Pneumococcal Conjugate Vaccine on Bacterial Meningitis in Madagascar.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  17. DONDO V, Mujuru H, Nathoo K, Jacha V, et al
    Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  18. AGOSSOU J, Ebruke C, Noudamadjo A, Adedemy JD, et al
    Declines in Pediatric Bacterial Meningitis in the Republic of Benin Following Introduction of Pneumococcal Conjugate Vaccine: Epidemiological and Etiological Findings, 2011-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available

  19. MWENDA JM, Soda E, Weldegebriel G, Katsande R, et al
    Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


    J Infect

  20. CHANG HY, Vuong J, Hu F, Liberator P, et al
    Distribution of Neisseria meningitidis serogroup B (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure.
    J Infect. 2019 Sep 7. pii: S0163-4453(19)30272.
    PubMed     Text format     Abstract available


    J Infect Dis

  21. MAY S, Mandal S, Keel P, Haywood B, et al
    Hepatitis B virus immunisation and neonatal acquisition of persistent infection in England and Wales.
    J Infect Dis. 2018 Apr 24. pii: 4982944. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
    Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
    J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. TIFREA DF, Pal S, de la Maza LM
    A recombinant Chlamydia trachomatis MOMP vaccine elicits cross-serogroup protection in mice against vaginal shedding and infertility.
    J Infect Dis. 2019 Aug 28. pii: 5555888. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. STACEY HD, Miller MS
    Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
    J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
    PubMed     Text format    

  25. KATELARIS AL, Jackson C, Southern J, Gupta RK, et al
    Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort.
    J Infect Dis. 2019 Aug 29. pii: 5556484. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. JOHNSON T, Folayan MO
    Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
    J Infect Dis. 2019;220:1233-1234.
    PubMed     Text format    

  27. HALPERIN SA, Das R, Onorato MT, Liu K, et al
    Immunogenicity, Lot Consistency, and Extended Safety of rVSVDeltaG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults.
    J Infect Dis. 2019;220:1127-1135.
    PubMed     Text format     Abstract available


    J Virol

  28. BLANCO JCG, Fernando LR, Zhang W, Kamali A, et al
    Alternative Virus-Like Particle-Associated Pre-Fusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    J Virol. 2019 Sep 11. pii: JVI.00914-19. doi: 10.1128/JVI.00914.
    PubMed     Text format     Abstract available

  29. LIU Y, Freed DC, Li L, Tang A, et al
    A Replication Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    J Virol. 2019 Sep 11. pii: JVI.00747-19. doi: 10.1128/JVI.00747.
    PubMed     Text format     Abstract available

  30. YE L, Ohnemus A, Ong LC, Gad HH, et al
    Type I and type III interferons differ in their adjuvant activities for influenza vaccines.
    J Virol. 2019 Sep 11. pii: JVI.01262-19. doi: 10.1128/JVI.01262.
    PubMed     Text format     Abstract available


    JAMA

  31. BERKLEY S
    The Power of Vaccines and How Gavi Has Helped Make the World Healthier: 2019 Lasker-Bloomberg Public Service Award.
    JAMA. 2019 Sep 10. pii: 2749793. doi: 10.1001/jama.2019.13190.
    PubMed     Text format    


    PLoS Comput Biol

  32. VENKATRAMANAN S, Chen J, Fadikar A, Gupta S, et al
    Optimizing spatial allocation of seasonal influenza vaccine under temporal constraints.
    PLoS Comput Biol. 2019;15:e1007111.
    PubMed     Text format     Abstract available

  33. BECKER AD, Wesolowski A, Bjornstad ON, Grenfell BT, et al
    Long-term dynamics of measles in London: Titrating the impact of wars, the 1918 pandemic, and vaccination.
    PLoS Comput Biol. 2019;15:e1007305.
    PubMed     Text format     Abstract available


    PLoS One

  34. CHAN JA, Wetzel D, Reiling L, Miura K, et al
    Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
    PLoS One. 2019;14:e0221733.
    PubMed     Text format     Abstract available

  35. KRAMSKAYA T, Leontieva G, Desheva Y, Grabovskaya K, et al
    Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice.
    PLoS One. 2019;14:e0222148.
    PubMed     Text format     Abstract available

  36. VON MOLLENDORF C, La Vincente S, Ulziibayar M, Suuri B, et al
    Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016.
    PLoS One. 2019;14:e0222423.
    PubMed     Text format     Abstract available


    Vaccine

  37. GOMES RR, Antunes DE, Dos Santos DF, Sabino EFP, et al
    BCG vaccine and leprosy household contacts: Protective effect and probability to becoming sick during follow-up.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31143.
    PubMed     Text format     Abstract available

  38. SALMON DA, Limaye RJ, Dudley MZ, Oloko OK, et al
    MomsTalkShots: An individually tailored educational application for maternal and infant vaccines.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31169.
    PubMed     Text format     Abstract available

  39. NAKAMURA K, Harada Y, Takahashi H, Trusheim H, et al
    Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31140.
    PubMed     Text format     Abstract available

  40. CHEN JY, Wu CM, Liao CM, Chen KC, et al
    The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31103.
    PubMed     Text format     Abstract available

  41. CHERIAN T, Morales KF, Mantel C, Lambach P, et al
    Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31000.
    PubMed     Text format     Abstract available

  42. VESTJENS SMT, Sanders EAM, Vlaminckx BJ, de Melker HE, et al
    Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31075.
    PubMed     Text format     Abstract available

  43. AN SH, Lee CY, Hong SM, Choi JG, et al
    Bioengineering a highly productive vaccine strain in embryonated chicken eggs and mammals from a non-pathogenic clade 2.3.4.4 H5N8 strain.
    Vaccine. 2019;37:6154-6161.
    PubMed     Text format     Abstract available

  44. TIPTON M, Daly W, Senders S, Block SL, et al
    MenACWY-CRM conjugate vaccine booster dose given 4-6years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults.
    Vaccine. 2019;37:6171-6179.
    PubMed     Text format     Abstract available

  45. YARNOFF B, Khavjou O, King G, Bates L, et al
    Analysis of the profitability of adult vaccination in 13 private provider practices in the United States.
    Vaccine. 2019;37:6180-6185.
    PubMed     Text format     Abstract available

  46. SMITH D, Streatfield SJ, Acosta H, Ganesan S, et al
    A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
    Vaccine. 2019;37:6162-6170.
    PubMed     Text format     Abstract available

  47. THOMPSON A, Lamberth E, Severs J, Scully I, et al
    Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
    Vaccine. 2019;37:6201-6207.
    PubMed     Text format     Abstract available

  48. SITT T, Kenney M, Barrera J, Pandya M, et al
    Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Vaccine. 2019;37:6221-6231.
    PubMed     Text format     Abstract available

  49. KAUFFMANN F, Van Damme P, Leroux-Roels G, Vandermeulen C, et al
    Clinical trials with GMO-containing vaccines in Europe: Status and regulatory framework.
    Vaccine. 2019;37:6144-6153.
    PubMed     Text format     Abstract available

  50. CHAN J, Nguyen CD, Dunne EM, Kim Mulholland E, et al
    Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31149.
    PubMed     Text format     Abstract available

  51. SAKURAI A, Ogawa T, Matsumoto J, Kihira T, et al
    Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31095.
    PubMed     Text format     Abstract available

  52. ELAISH M, Xia M, Ngunjiri JM, Ghorbani A, et al
    Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31171.
    PubMed     Text format     Abstract available

  53. KEITEL WA, Potter GE, Diemert D, Bethony J, et al
    A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31151.
    PubMed     Text format     Abstract available

  54. LI XR, Yang YK, Wang RB, An FL, et al
    A scale-down model of 4000-L cell culture process for inactivated foot-and-mouth disease vaccine production.
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31201.
    PubMed     Text format     Abstract available

  55. COSTANTINO V, MacIntyre CR, Trent M
    Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31145.
    PubMed     Text format     Abstract available

  56. WIYEH AB, Cooper S, Jaca A, Mavundza E, et al
    Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31219.
    PubMed     Text format     Abstract available

  57. BURNETT EM, Francois J, Sreenivasan N, Wannemuehler K, et al
    Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31218.
    PubMed     Text format     Abstract available

  58. CHOW EPF, Danielewski JA, Murray GL, Fehler G, et al
    Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31142.
    PubMed     Text format     Abstract available

  59. FOUGERE Y, El Houss S, Suris JC, Rouvenaz-Defago S, et al
    Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children.
    Vaccine. 2019 Sep 12. pii: S0264-410X(19)31192.
    PubMed     Text format     Abstract available

  60. CONNOCHIE D, Tingler RC, Bauermeister JA
    Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31152.
    PubMed     Text format     Abstract available

  61. MCLAUGHLIN JM, Jiang Q, Gessner BD, Swerdlow DL, et al
    Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis.
    Vaccine. 2019 Sep 12. pii: S0264-410X(19)31135.
    PubMed     Text format     Abstract available

  62. YU X, Zhang T, Cui L, Geng X, et al
    Corrigendum to "Epidemiology study of pediatric primary intussusception aged </=24months in pre-rotavirus vaccine era of Jinan, China" [Vaccine (37) 1436-1442].
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31070.
    PubMed     Text format    

  63. PEZZOLI L
    Global oral cholera vaccine use, 2013-2018.
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31185.
    PubMed     Text format     Abstract available

  64. UMTHONG S, Dunn JR, Cheng HH
    Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31189.
    PubMed     Text format     Abstract available

  65. BERNSTEIN DI, Cardin RD, Bravo FJ, Hamouda T, et al
    Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31153.
    PubMed     Text format     Abstract available

  66. TORRES JR, Falleiros-Arlant LH, Gessner BD, Delrieu I, et al
    Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31198.
    PubMed     Text format     Abstract available

  67. ARYA DP, Said MA, Izurieta HS, Perez-Vilar S, et al
    Surveillance for Guillain-Barre syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31109.
    PubMed     Text format     Abstract available

  68. NOAD RJ, Simpson K, Fooks AR, Hewson R, et al
    UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
    Vaccine. 2019 Sep 12. pii: S0264-410X(19)31197.
    PubMed     Text format     Abstract available

  69. QUATTROCCHI A, Mereckiene J, Fitzgerald M, Cotter S, et al
    Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31196.
    PubMed     Text format     Abstract available

  70. WANG LY, Chen CF, Wu TW, Lai SK, et al
    Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31186.
    PubMed     Text format     Abstract available

  71. XU J, Hiramatsu R, Suhaimi H, Kato T, et al
    Neospora caninum antigens displaying virus-like particles as a bivalent vaccine candidate against neosporosis.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31187.
    PubMed     Text format     Abstract available

  72. ZEEVAT F, van der Schans J, Boersma WG, Boersma C, et al
    Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31125.
    PubMed     Text format     Abstract available


    Virology

  73. ZHANG C, Zheng YY, Gong YM, Zhao Z, et al
    Evaluation of immune response and protection against spring viremia of carp virus induced by a single-walled carbon nanotubes-based immersion DNA vaccine.
    Virology. 2019;537:216-225.
    PubMed     Text format     Abstract available


    Virus Res

  74. AZIZ F, Tufail S, Shah MA, Salahuddin Shah M, et al
    In silico Epitope Prediction and Immunogenic Analysis for Penton base Epitope-focused Vaccine against Hydropericardium syndrome in chicken.
    Virus Res. 2019 Sep 8:197750. doi: 10.1016/j.virusres.2019.197750.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: